Long-lasting occupancy of central nicotinic acetylcholine receptors after smoking: A PET study in monkeys

Journal of Neurochemistry

Volumn 84, Issue 1, 2003, Pages 105-111

  Valette, Héric ^a   Bottlaender, Michel ^a   Dollé, Frédéric ^a   Coulon, Christine ^a   Ottaviani, Michèle ^a   Syrota, André ^a  

^a DIF   (France)

Author keywords

4 2 nicotinic receptors; 18F Fluoro A 85380; Baboon brain; Inhalation of tobacco smoke; Nicotine; Positron emission tomography

Indexed keywords

NICOTINIC RECEPTOR; NORNICOTINE;

ANIMAL TISSUE; ARTICLE; BABOON; CIGARETTE SMOKING; CONTROLLED STUDY; HALF LIFE TIME; MALE; MONKEY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PUTAMEN; THALAMUS;

ANIMALS; BRAIN; INJECTIONS, INTRAVENOUS; MALE; NICOTINE; NICOTINIC AGONISTS; PAPIO; RECEPTORS, NICOTINIC; REFERENCE VALUES; SMOKING; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

ANIMALIA; NICOTIANA TABACUM; PAPIO HAMADRYAS;

EID: 0037269321     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01502.x     Document Type: Article

References (25)

1. Broussolle E. P., Wong D. F., Fanelli R. J. and London E. D. (1989) In vivo specific binding of 3H-nicotine in the mouse brain. Life Sci. 44, 1123-1132.
2. Bush L. P., Fannin F. F., Chelvarajan R. L. and Burton H. R. (1993) Biosynthesis and metabolism of nicotine and related alkaloids, in Nicotine and Related Alkaloids: Absorption, Distribution, Metabolism and Excretion. (Gorrod J. W. and Wahren J., eds), pp. 1-30. Chapman & Hall, London.
3. Chefer S. I., Horti A. G., Koren A. O., Gündisch D., Links J. M., Kurian V., Dannals R. F., Mukhin A. G. and London E. D. (1999) 2-[18F]F-A-85380: a PET radioligand for α4β2 nicotinic acetylcholine receptors. Neuroreport 10, 2715-2721.
4. Crooks P. A., Li M. and Dwoskin L. P. (1997) Metabolites of nicotine in rat brain after peripheral nicotine administration. Cotinine, nornicotine and norcotinine. Drug. Metab. Disp. 25, 47-54.
5. Damaj M. I., Fei-Yin M., Dukat M., Glassco W., Glennon R. A. and Martin B. R. (1998) Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. J. Pharmacol. Exp. Ther. 284, 1058-1065.
6. Ding Y. S., Volkow N. D., Logan J., Garza V., Pappas N., King P. and Fowler J. S. (2000) Occupancy of brain nicotinic acetylcholine receptors by nicotine doses equivalent to those obtained when smoking a cigarette. Synapse 35, 234-237.
7. Dollé F., Dolci L., Valette H., Hinnen F., Vaufrey F., Guenther I., Fuseau C., Coulon C., Bottlaender M. and Crouzel C. (1999) Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2 (S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors. J. Med. Chem. 42, 2251-2259.
8. Flood P., Ramirez-Latorre J. and Role L. (1997) α4β2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but 7-type nicotinic acetylcholine receptors are unaffected. Anesthesiology 86, 859-865.
9. Fujita M., Tamagnan G., Zoghbi S. S., Al-Tikriti M. S., Baldwin R. M., Seibyl J. P. and Innis R. B. (2000) Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT. J. Nucl. Med. 9, 1552-1560.
10. 14C]nicotine. Drug. Metab. Disp. 27, 1448-1455.
11. Green T. A., Phillips S. B., Crooks P. A., Dwoskin L. P. and Bardo M. T. (2000) Nornicotine pretreatment decreases intravenous nicotine self-administration in rats. Psychopharmacology (Berlin) 152, 289-294.
12. Green T. A., Crooks P. A., Bardo M. T. and Dwoskin L. P. (2001) Contributory role for nornicotine in nicotine neuropharmacology: nornicotine-evoked [3H]dopamine overflow from rat nucleus accumbens slices. Biochem. Pharmacol. 62, 1597-1603.
13. 11C]cotinine. Preparation, metabolite studies and in vivo distribution in the human brain using PET. Nucl. Med. Biol. 19, 871-880.
14. Holladay M. W., Bai H., Li Y., Lin N. H., Daanen J. F., Ryther K. B., Wasicak J. T., Kincaid J. F., Hettinger A. M., Huang P., Anderson D. J., Bannon A. W., Buckley M. J., Campbell J. E., Donnelly-Roberts D. L., Gunther K. L., Kim D. J. B., Kuntzweiler T. A., Sullivan J. P., Decker M. W. and Arneric S. P. (1998) Structure-activity studies related to ABT-594, a potent non opioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice. Bioorg. Med. Chem. Lett. 8, 2797-2802.
15. 18F]FHP for PET imaging of nicotinic acetylcholine receptors. J. Nucl. Med. 38, 1250-1265.
16. Muzic R. F. Jr, Berridge M. S., Friedland R. P., Zhu N. and Nelson A. D. (1998) PET quantification of specific binding of carbon-11-nicotine in human brain. J. Nucl. Med. 39, 2048-2054.
17. Nybäck H., Halldin C., Ahlin A., Curvall M. and Eriksson L. (1994) PET studies of the uptake of (S)- and (R)-11C-nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo. Psychopharmacol. 115, 31-36.
18. 18F]F-A-85380, a novel PET ligand for α4β2 nicotinic receptors. Soc. Neurosci. Abst. 26, 627 (abstract).
19. Raines D. E. and Zachariah V. T. (2000) Isoflurane increases the apparent agonist affinity of the nicotinic acetylcholine receptor by reducing the microscopic agonist dissociation constant. Anesthesiology 92, 775-785.
20. Riche D., Hantraye P., Guibert B., Naquet R., Loch C., Mazière B. and Mazière M. (1988) Anatomical atlas of the baboon's brain in the orbito-meatal plane used in experimental positron emission tomography. Brain Res. Bull. 20, 283-287.
21. Risner M. E., Goldberg S. R., Prada J. A. and Cone J. E. (1985) Effects of nicotine, cocaine and some of their metabolites on schedule controlled responding by beagle dogs and squirrel monkeys. J. Pharmacol. Exp. Ther. 234, 113-119.
22. Sihver W., Fasth K. J., Ogren M., Lundqvist H., Bergstrom M., Watanabe Y., Langstrom B. and Nordberg A. (1999) In vivo positron emission tomography studies on the novel nicotinic receptor agonist [11C]MPA compared with [11C]ABT-418 and (S)(-)[11C]nicotine in rhesus monkeys. Nucl. Med. Biol. 26, 633-640.
23. Sihver W., Nordberg A., Langstrom B., Mukhin A. G., Koren A. O., Kimes A. S. and London E. D. (2000) Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behav. Brain Res. 113, 143-157.
24. Valette H., Bottlaender M., Dollé F., Guenther I., Coulon C., Hinnen F., Fuseau C., Ottaviani M. and Crouzel C. (1998) Characterization of the nicotinic ligand 2-[18F]Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo. Life Sci. 64, PL93-97.
25. Valette H., Bottlaender M., Dollé F., Guenther I., Fuseau C., Coulon C., Ottaviani M. and Crouzel C. (1999) Imaging central nicotinic acetylcholine receptors in baboons with [18F]Fluoro-A-85380. J. Nucl. Med. 40, 1374-1380.